Anti-obesity_Drugs_Market_Size

  The increasing prevalence of chronic diseases among the geriatric population is driving the “ Netherlands home healthcare market ”. The above information is published in a report, titled “Netherlands Home Healthcare: Market Analysis, Insights and Forecast, 2019-2026.” Fortune Business Insights in the report predicts that rising geriatric population in the Netherlands is leading to high demand for home healthcare equipment. A study by Central Bureau Statistics (CBU), it is estimated that around 3.31 million people in the Netherlands are aged above 65 years. Also, the study predicts that the number will increase by 2026. This further indicates that the adoption of home healthcare products will increase in the forthcoming years. As per the report by Fortune Business Insights, the Netherlands market was worth US$ 570.0 Mn in 2018 and is anticipated to reach US$ 1013.1 Mn by 2026. As home healthcare is a viable option and increasingly adopted by the elderly population, the market for home

  The global “ hepatitis C drugs market ” will derive growth impetus from the high prevalence of hepatitis C across the world. According to a report published by Fortune Business Insights, titled “Hepatitis C Drugs: Global Market Analysis, Insights and Forecast, 2019-2026,” the market was valued at US$ 7,866.6 Mn in 2018. Fortune Business Insights states that the market is projected to reach US$ 7,351.7 Mn by 2026, exhibiting a CAGR of -0.9% in the forecast period. Hepatitis C requires oral injections and dosages on a weekly basis, and it also has several side effects that can also lead to permanent damage. Increasing clinical trials and successful drug clearances have aided the overall growth of the global hepatitis C market. Increasing number of regulatory approvals will boost the global hepatitis C market in the forthcoming years. Hepatitis C is a viral infection that causes severe damage such as inflammation of the liver and can spread through contaminated blood. The advanced stage

  The global “ stomach cancer treatment ” market size is expected to reach USD 8.20 billion by 2026, exhibiting a CAGR of 15.3% during the forecast period. One of the major forces behind the rise of this market is the increasing prevalence of cancer in general and stomach cancer in particular worldwide. The GLOBOCAN 2018, which is a report on the global burden of cancer produced by the International Agency for Research on Cancer (IARC), estimates that in 2018, new cancer cases will be around 18 million and cancer-related deaths will be close to 9.6 million. Further, stomach cancer will account for 8.2% of the new cancer cases. Statistics released by the World Cancer Research Fund (WCRF) substantiate the IARC’s findings. According to the WCRF, gastric cancer is the fourth mostly commonly diagnosed cancer worldwide, with 1 million new reported cases. As the incidence of stomach cancer increases across the globe, the demand for stomach cancer drugs will rise commensurately, spelling good

  The global “ non-steroidal anti-inflammatory drugs ” market is set to gain momentum from the ever-increasing research activities by several prominent pharmaceutical companies on selective cyclooxygenase-2 inhibitors as they are still a grey area for these companies. Tough, Non-steroidal Anti-Inflammatory Drugs such as ibuprofen and diclofenac are nowadays used to hinder the activity of COX, but they have undesirable effect. Fortune Business Insights™ published this information in a new report, titled, “Non-steroidal Anti-Inflammatory Drugs (Non-steroidal Anti-Inflammatory Drugs) Market Size, Share & Industry Analysis, By Disease Indication (Arthritis, Migraine, Ophthalmic Diseases, and Others), By Route of Administration (Oral, and Parenteral), By Distribution Channel (Hospital Pharmacy Retail Pharmacy, and Online Pharmacy), and Regional Forecast, 2020-2027.” The report further mentions that the Non-Steroidal Anti-Inflammatory Drugs market size was USD 15.58 billion in 2019 and i

  Global   Lymphoma Treatment Market   | 2021 Global Healthcare Industry Analysis To 2028, is latest report on Global Lymphoma Treatment Industry, published by Fortune Business Insights. According to this report Global Lymphoma Treatment Market to rise at healthy Compound Annual Growth Rate by 2028. Market for Lymphoma Treatment Industry is segmented By Product Type (Lymphoma Treatment Frames and Spectacle Lenses), By Modality (Prescription and Over-the-counter) By Distribution Channel (Retail Store, Online Store, Ophthalmic Clinics), and Regional Forecast, 2019-2026 Major Lymphoma Treatment Manufacturers covered in the market report include: Takeda Pharmaceutical Company Limited AstraZeneca Bayer AG Novartis AG Kite Pharma, Inc. / Gilead Sciences, Inc. Spectrum Pharmaceuticals, Inc. Teva Pharmaceutical Industries Ltd. Bristol Myers Squibb Company Janssen Pharmaceuticals, Inc. Get Sample PDF Brochure of Lymphoma Treatment Market Report at: https://www.fortunebusinessinsights.com/enquir

  Global   Ophthalmic Diagnostic Devices   Market | 2021 Global Healthcare Industry Analysis To 2028, is latest report on Global Ophthalmic Diagnostic Devices Industry, published by Fortune Business Insights. According to this report Global Ophthalmic Diagnostic Devices Market to rise at healthy Compound Annual Growth Rate by 2028. Market for Ophthalmic Diagnostic Devices Industry is segmented By Product Type (Ophthalmic Diagnostic Devices Frames and Spectacle Lenses), By Modality (Prescription and Over-the-counter) By Distribution Channel (Retail Store, Online Store, Ophthalmic Clinics), and Regional Forecast, 2019-2026 Major Ophthalmic Diagnostic Devices Manufacturers covered in the market report include: Optovue, Incorporated ZEISS International AMETEK, Inc. Alcon NIDEK CO., LTD. Essilor TOPCON HAAG-STREIT GROUP Other prominent players Hologic, Inc. and other key market players. Get Sample PDF Brochure Of Ophthalmic Diagnostic Devices Market Report at: https://www.fortunebusinessins

  The global “ influenza medication market ” size is projected to reach USD 993.7 million by 2026, exhibiting a CAGR of 2.2% during the forecast period. Increasing global burden of influenza will be one of the central forces driving the growth of this market. Influenza, or the flu, is a virus that infects the human respiratory system, that is, the throat, lungs, and nose. Usually, the infection subsides on its own, but sometimes it can turn severe and even prove to be fatal. According to the World Health Organization (WHO), every year influenza epidemics around the globe affect around 3 million to 5 million people and cause respiratory deaths between 290,000 and 650,000. The developed nations are also bearing the impact of this deadly virus. For instance, the US Centers for Disease Control and Prevention (CDC) states that since 2010, the occurrence of influenza-related illnesses in the US have been between 9 million and 45 million. In 2016-17, the CDC estimates that hospitalizations re